It is a pharma private limited company based in Madurai, Tamil Nadu, India, established in 2009.
2009 | Madurai, Tamil Nadu, India | ActiveParis-Dakner Nanolifesciences Private Limited, a active private limited company, was established on 26 August 2009 in Madurai, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U15323TN2009PTC072701. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.10 M.
Formerly known as Glorex Medicare Private Limited. It upholds a active non-compliant status. Its leadership includes Sathish Kumar Muthupillai (Managing Director), Mohanasundram Madhumathi (Additional Director), Vignesh Mohanasundaram (Additional Director). Past directors included Anandvivek Bajpai, Arumugam Rathakrishnan, Mohanasundaram Umarani. It holds ₹0.17 M open charges and no settled loans. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at Shed No:56, Mahia Industrial Area, Uranganpatti,, Madurai, Tamil Nadu, 625020.
U15323TN2009PTC072701
072701
26 August 2009
₹2.50 M
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Paris-Dakner Nanolifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sathish Kumar Muthupillai | Managing Director | 01 Feb 2014 | Current |
| Mohanasundram Madhumathi | Additional Director | 25 Mar 2014 | Current |
| Vignesh Mohanasundaram | Additional Director | 29 Mar 2014 | Current |
| Kunasekaran Arun Pradeep | Additional Director | 29 Mar 2014 | Current |
| Anandvivek Bajpai | Director | 14 Jun 2013 | Current |
| Mohanasundaram Umarani | Director | 14 Jun 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 10 Jan 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 17 Jun 2013 | Past |
| Pramod Abcsdd | Director | 17 Jun 2013 | Past |
| Pramod Abcsdd | Managing Director | 17 Jun 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Paris-Dakner Nanolifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Paris-Dakner Nanolifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹170,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 2010 | Indian Overseas Bank | ₹0.17 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Paris-Dakner Nanolifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Paris-Dakner Nanolifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paris-Dakner Nanolifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Vignesh Mohanasundaram was appointed as a Additional Director was appointed as a Additional Director on 29 Mar 2014 & has been associated with this company since 11 years 8 months . was recorded as a recent event.
Progress on Kunasekaran Arun Pradeep was appointed as a Additional Director was appointed as a Additional Director on 29 Mar 2014 & has been associated with this company since 11 years 8 months . was documented.
The activity Mohanasundram Madhumathi was appointed as a Additional Director was appointed as a Additional Director on 25 Mar 2014 & has been associated with this company since 11 years 8 months . was completed.
Sathish Kumar Muthupillai was appointed as a Managing Director was appointed as a Managing Director on 01 Feb 2014 & has been associated with this company since 11 years 10 months . was recorded as a recent event.
Progress on Paris-Dakner Nanolifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was documented.
Progress on Anandvivek Bajpai was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 12 years 6 months . was documented.
The CIN of Paris-Dakner Nanolifesciences Private Limited is U15323TN2009PTC072701.
Paris-Dakner Nanolifesciences Private Limited is headquartered at Shed No:56, Mahia Industrial Area, Uranganpatti,, Madurai, Tamil Nadu, 625020.
Paris-Dakner Nanolifesciences Private Limited was incorporated on 26 August 2009.
The current directors of Paris-Dakner Nanolifesciences Private Limited are
The primary industry of Paris-Dakner Nanolifesciences Private Limited is Pharma.
Paris-Dakner Nanolifesciences Private Limited is unlisted.
The authorized capital of Paris-Dakner Nanolifesciences Private Limited is ₹2.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Paris-Dakner Nanolifesciences Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX